Major Depressive Disorder Market Analysis and Sales Forecast Report 2024: Across the 68 Markets Covered, Sales in the MDD Market were $8.8 Billion in 2019, Growing to $16.2 Billion in 2029 Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.This report covers the...

Japan Major Depressive Disorder (MDD) Market Forecast and Opportunities 2020-2030: Increasing Awareness and Decreasing Stigma of Mental Health Disorders Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Japan Major Depressive Disorder (MDD) Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ...

Major Depressive Disorder Market to Register Stunning Growth During the Forecast Period (2023–2032), Examines DelveInsight | Leading Companies - Otsuka, Sumitomo, COMPASS, Sage, Neurocrine, Boehringer Ingelheim, Janssen New York, USA, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Major Depressive Disorder Market to Register Stunning Growth During the Forecast Period (2023–2032), Examines DelveInsight | Leading Companies -...

Major Depressive Disorder Pipeline: Insights into Leading Pharma Players, Novel Emerging Therapies, Clinical Trials and Future Outlook | DelveInsight   Los Angeles, USA, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Major Depressive Disorder Pipeline: Insights into Leading Pharma Players, Novel Emerging Therapies, Clinical Trials and Future Outlook |...

Major Depressive Disorder Pipeline: Insights into Leading Pharma Players, Novel Emerging Therapies, Clinical Trials and Future Outlook | DelveInsight   Los Angeles, USA, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Major Depressive Disorder Pipeline: Insights into Leading Pharma Players, Novel Emerging Therapies, Clinical Trials and Future Outlook |...